Development of the treatment strategy for HCV-related diseases using ultra-deep sequencing technology.
Project/Area Number |
24590965
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | University of Yamanashi |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
ENOMOTO Nobuyuki 山梨大学, 総合研究部, 教授 (20251530)
MIURA Mika 山梨大学, 総合研究部, 助教 (00436875)
KOMATSU Nobutoshi 山梨大学, 総合研究部, 助教 (50568003)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | HCV / Ultra-deep sequence / DAA / 耐性変異 / Quasispecies / 系統樹 / Ultra-deep sequencing / 3者併用療法 |
Outline of Final Research Achievements |
It has been hard to predict the treatment response of HCV-infected patients to the most advanced DAA-included therapy. Using ultra-deep sequencing technology coupled with phylogenetic analysis, this study was conducted to disclose the role of viral quasispecies in determining the treatment response to DAA-included anti-HCV therapy. As a result, it was disclosed that viral quasispecies changed dynamically and certain viral isolates were selected with the introduction of DAA-based therapy. The result of the study provides better understanding of the mechanism in the appearance of DAA resistance.
|
Report
(4 results)
Research Products
(19 results)
-
[Journal Article] Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.2015
Author(s)
Sato M, Maekawa S, Komatsu N, Tatsumi A, Miura M, Muraoka M, Suzuki Y, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Uetake T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.
-
Journal Title
J Virol
Volume: 89(11)
Issue: 11
Pages: 6105-16
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to IL28B genotype and are sensitive to interferon-based therapy.2015
Author(s)
Itakura J, Kurosaki M, Takada H, Nakakuki N, Matsuda S, Gondou K, Asano Y, Hattori N, Itakura Y, Tamaki N, Yasui Y, Suzuki S, Hosokawa T, Tsuchiya K, Nakanishi H, Takahashi Y, Maekawa S, Enomoto N, Izumi N.
-
Journal Title
Hepatol Res.
Volume: [Epub ahead of print]
Issue: 10
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Hallmarks of hepatitis C virus in equine hepacivirus.2015
Author(s)
Tanaka T, Kasai H, Yamashita A, Okuyama-Dobashi K, Yasumoto J, Maekawa S, Enomoto N, Okamoto T, Matsuura Y, Morimatsu M, Manabe N, Ochiai K, Yamashita K, Moriishi K.
-
Journal Title
J Virol.
Volume: 88(22)
Issue: 22
Pages: 13352-66
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging.2015
Author(s)
Komatsu N, Motosugi U, Maekawa S, Shindo K, Sakamoto M, Sato M, Tatsumi A, Miura M, Amemiya F, Nakayama Y, Inoue T, Fukasawa M, Uetake T, Ohtaka M, Sato T, Asahina Y, Kurosaki M, Izumi N, Ichikawa T, Araki T, Enomoto N.
-
Journal Title
Hepatol Res
Volume: -
Issue: 13
Pages: 1339-1346
DOI
Related Report
Peer Reviewed
-
[Journal Article] Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection.2014
Author(s)
Miura M, Maekawa S, Sato M, Komatsu N, Tatsumi A, Takano S, Amemiya F, Nakayama Y, Inoue T, Sakamoto M, Enomoto N.
-
Journal Title
Hepatol Res.
Volume: Feb 25
Issue: 14
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Inhibitory effects of caffeic Acid phenethyl ester derivatives on replication of hepatitis C virus.2013
Author(s)
Shen H, Yamashita A, Nakakoshi M, Yokoe H, Sudo M, Kasai H, Tanaka T, Fujimoto Y, Ikeda M, Kato N, Sakamoto N, Shindo H, Maekawa S, Enomoto N, Tsubuki M, Moriishi K.
-
Journal Title
PLoS One.
Volume: 17
Issue: 1
Pages: 163-164
DOI
Related Report
Peer Reviewed
-
[Journal Article] Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression.2013
Author(s)
Miura M, Maekawa S, Takano S, Komatsu N, Tatsumi A, Asakawa Y, Shindo K, Amemiya F, Nakayama Y, Inoue T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.
-
Journal Title
J Virol.
Volume: 87(23)
Issue: 23
Pages: 12541-12551
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Serum RANTES level influences the response to pegylated interferon and ribavirin therapy in chronic hepatitis C.2013
Author(s)
Komase K, Maekawa S, Miura M, Sueki R, Kadokura M, Shindo H, Shindo K, Amemiya F, Nakayama Y, Inoue T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N
-
Journal Title
Hepatol Res.
Volume: 43(8)
Issue: 8
Pages: 865-875
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-